Genome Therapeutics to Sequence Genome of Undisclosed Pathogen for Wyeth-Lederle | GenomeWeb

NEW YORK, Feb 1 – Genome Therapeutics has agreed to sequence the genome of an undisclosed pathogenic organism for Wyeth-Lederle Vaccines, the companies said Thursday.

The name of the pathogen remains confidential under the agreement, and Wyeth-Lederle Research spokesman Doug Petkus would say only that the genome “will be useful for our discovery efforts.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.